Catalyst Wire Dossier Catalyst Wire Dossier

ND4 gene therapy

ND4 gene therapy · Neurophth Therapeutics Inc
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ND4 gene therapy, covering 2024-09-04 to 2024-09-04. Get the full timeline:

Most recent: Clinical Trial Update: Gene Therapy Clinical Trial for the Treatment of Leber's Hereditary Optic Neuropathy Associated With ND4 Mutations [Phase 1, Phase 2]

See pricing